Summary

Astellas Pharma Inc. - Company Profile and SWOT Analysis

Summary

Astellas Pharma Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Astellas Pharma Inc. (Astellas) manufactures, markets, develops, imports, and export of pharmaceuticals and related products. It manufactures prescription drugs in therapeutic areas of urology, nephrology, oncology, immunology, muscle diseases and neuroscience. It provides drugs for different types of cancer, including prostate cancer, urothelial cancer and anemia associated with chronic kidney disease. The company sells its products under Gaster, Geninax Gonax, Harnal/Omnic, Geninax, Funguard, Prograf, Vesicare, and Eligard among others brand names. Astellas operates research centers in Japan. The company has business operations across Japan, Europe, the Middle East, the Americas, and Africa (EMEA), Asia, and Oceania. The company is headquartered in Chuo-Ku, Tokyo, Japan.

Scope

- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
- Intelligence on Astellas Pharma Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Astellas Pharma Inc.'s business structure, strategy and prospects.

ページTOPに戻る

Table of Contents

Table of Contents
Company Snapshot
Astellas Pharma Inc.: Company Overview
Astellas Pharma Inc.: Overview and Key Facts
Astellas Pharma Inc.: Overview
Astellas Pharma Inc.: Key Facts
Astellas Pharma Inc.: Key Employees
Astellas Pharma Inc.: Key Employee Biographies
Astellas Pharma Inc.: Major Products and Services
Astellas Pharma Inc.: Management Statement
Astellas Pharma Inc.: Locations and Subsidiaries
Astellas Pharma Inc.: Key Competitors
Astellas Pharma Inc.: Company Analysis
Astellas Pharma Inc.: Business Description
Astellas Pharma Inc.: SWOT Analysis
Astellas Pharma Inc.: SWOT Overview
Astellas Pharma Inc.: Strengths
Astellas Pharma Inc.: Weaknesses
Astellas Pharma Inc.: Opportunities
Astellas Pharma Inc.: Threats
Astellas Pharma Inc.: Corporate Financial Deals Activity
Astellas Pharma Inc.: Financial Deals Overview
Astellas Pharma Inc.: Targets and Partners
Astellas Pharma Inc.: Top Deals 2022 - 2026YTD*
Astellas Pharma Inc.: Advisors
Astellas Pharma Inc.: Top Legal Advisors
Astellas Pharma Inc.: Top Financial Advisors
Astellas Pharma Inc.: Mergers and Acquisitions
Astellas Pharma Inc.: Corporate Venturing
Astellas Pharma Inc.: Capital Raising
Astellas Pharma Inc.: Partnership
Astellas Pharma Inc.: Divestments
Astellas Pharma Inc.: Recent Developments
Astellas Pharma Inc.: News and Events Summary
Astellas Pharma Inc.: Business Expansion
Astellas Pharma Inc.: Contracts
Astellas Pharma Inc.: Corporate Governance
Astellas Pharma Inc.: Financial Deals
Astellas Pharma Inc.: Financial Performance
Astellas Pharma Inc.: Market Developments
Astellas Pharma Inc.: Regulatory and Legal Events
Astellas Pharma Inc.: Research & Development
Astellas Pharma Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1: Astellas Pharma Inc.: Key Facts
Table 2: Astellas Pharma Inc.: Key Employees
Table 3: Astellas Pharma Inc.: Locations and Subsidiaries
Table 4: Astellas Pharma Inc.: Key Competitors
Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 7: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Astellas Pharma Inc.: Targets and Partners
Table 9: Astellas Pharma Inc.: Top Deals 2022 - 2026YTD*
Table 10: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Astellas Pharma Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Astellas Pharma Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Table 13: Astellas Pharma Inc.: M&A Activity by Geography (2022 - YTD*2026)
Table 14: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026)
Table 15: Astellas Pharma Inc.: Corporate Venturing by Geography (2022 - YTD*2026)
Table 16: Astellas Pharma Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Table 17: Astellas Pharma Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Table 18: Astellas Pharma Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 19: Astellas Pharma Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Table 20: Astellas Pharma Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
Table 21: Astellas Pharma Inc.: News and Events Summary
Table 22: Astellas Pharma Inc.: Business Expansion
Table 23: Astellas Pharma Inc.: Contracts
Table 24: Astellas Pharma Inc.: Corporate Governance
Table 25: Astellas Pharma Inc.: Financial Deals
Table 26: Astellas Pharma Inc.: Financial Performance
Table 27: Astellas Pharma Inc.: Market Developments
Table 28: Astellas Pharma Inc.: Regulatory and Legal Events
Table 29: Astellas Pharma Inc.: Research & Development
Table 30: Astellas Pharma Inc.: Strategy and Operations
List of Figures
Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 3: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Astellas Pharma Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Figure 5: Astellas Pharma Inc.: M&A Activity by Geography (2022 - YTD*2026)
Figure 6: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026)
Figure 7: Astellas Pharma Inc.: Corporate Venturing by Geography (2022 - YTD*2026)
Figure 8: Astellas Pharma Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Figure 9: Astellas Pharma Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Figure 10: Astellas Pharma Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 11: Astellas Pharma Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Figure 12: Astellas Pharma Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)